Long-term suppression of adult bladder morbidity and severe hydronephrosis following selective population chemotherapy for Schistosoma haematobium.

A K Subramanian Department of Medicine, University Hospitals of Cleveland and Case Western Reserve University, Ohio 44106-4983, USA.

Search for other papers by A K Subramanian in
Current site
Google Scholar
PubMed
Close
,
P Mungai Department of Medicine, University Hospitals of Cleveland and Case Western Reserve University, Ohio 44106-4983, USA.

Search for other papers by P Mungai in
Current site
Google Scholar
PubMed
Close
,
J H Ouma Department of Medicine, University Hospitals of Cleveland and Case Western Reserve University, Ohio 44106-4983, USA.

Search for other papers by J H Ouma in
Current site
Google Scholar
PubMed
Close
,
P Magak Department of Medicine, University Hospitals of Cleveland and Case Western Reserve University, Ohio 44106-4983, USA.

Search for other papers by P Magak in
Current site
Google Scholar
PubMed
Close
,
C H King Department of Medicine, University Hospitals of Cleveland and Case Western Reserve University, Ohio 44106-4983, USA.

Search for other papers by C H King in
Current site
Google Scholar
PubMed
Close
,
A A Mahmoud Department of Medicine, University Hospitals of Cleveland and Case Western Reserve University, Ohio 44106-4983, USA.

Search for other papers by A A Mahmoud in
Current site
Google Scholar
PubMed
Close
, and
C L King Department of Medicine, University Hospitals of Cleveland and Case Western Reserve University, Ohio 44106-4983, USA.

Search for other papers by C L King in
Current site
Google Scholar
PubMed
Close
Restricted access

Repeated selective population chemotherapy of school age children reduces infection and morbidity associated with Schistosoma haematobium infection. To examine the long-term effect of this treatment on susceptibility to re-infection and late disease, a cohort of Kenyans (n = 194) were re-examined for infection and urinary tract morbidity 7-13 years after they underwent annual ultrasonography and treatment for an average of 5 years beginning in 1984 as children. Controls were previously untreated age-matched individuals residing in the same or adjacent villages. The overall prevalence and intensity of infection were equivalent between the 2 groups. In contrast, the prevalence of bladder wall pathology was 11-fold lower in previously treated (1.5%) versus untreated subjects (17%). Severe hydronephrosis was completely reversed. These data demonstrate that treatment significantly reduced urinary tract morbidity despite re-infection, and suggest that the important risk factors for urinary tract morbidity in adulthood are cumulative intensity and duration of infection during early adolescence.

Save